bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.07.13.499912

Reproducibility of Principal and Independent Genomic Components of Brain Structure and Function

Abstract

IntroductionThe highly polygenic and pleiotropic nature of behavioural traits, psychiatric disorders, and structural and functional brain phenotypes complicate mechanistic interpretation of related genome-wide association study (GWAS) signals, such that the underlying causal biological processes remain obscure. We propose the novel method of genomic principal and independent component analysis (PCA, ICA) to decompose a large set of univariate GWAS statistics of multimodal brain traits into more interpretable latent genomic components. Here we introduce this new method and evaluate its various analytic parameters and reproducibility across independent samples. MethodsTwo releases of GWAS summary statistics from the UK biobank (UKB), with 11,086 and 22,138 participants respectively, were retrieved from the Oxford BIG-40 server. GWAS summary statistics were clumped resulting in n=165,364 single nucleotide polymorphisms (SNP) and m=2,240 imaging derived phenotypes (IDPs). Both genome-wide beta-values and their corresponding, standard-error scaled z-values were decomposed using multivariate exploratory linear optimised decomposition into independent components (MELODIC). We evaluated variance explained at multiple dimensions up to 200. We tested the reproducibility of output of dimensions 5, 10, 25, and 50 by computing Pearsons correlation between component loadings, and Fisher Exact tests on overlap of the top SNP loadings across samples. Reproducibility statistics of the original raw and z-transformed univariate GWAS served as benchmarks. We also inspected the clustering of genomic components across neuroimaging modalities using t-SNE. ResultsThe first five PCs derived from z-transformed GWAS captured 31.9% of the variance across SNP effect sizes, while 200 PCs increased the variance explained to 79.6%. Reproducibility of 10-dimensional PCs and ICs showed the best balance between model complexity and robustness, and variance explained (PCs: |rz-max|=0.33, |rraw-max|=0.30; ICs: |rz-max|=0.23, |rraw-max|=0.19), with decreasing model stability and reproducibility at higher dimensions. Both genomic PC and IC reproducibilities improved substantially relative to mean univariate GWAS reproducibility up to a dimension of 10. Genomic components clustered along neuroimaging modalities. ConclusionOur results indicate that these novel methods of genomic ICA and PCA decompose genetic effects on IDPs from raw GWAS statistics with high reproducibility by taking advantage of the inherent pleiotropic patterns. These findings encourage further applications of genomic ICA and PCA as fully data-driven methods to effectively reduce the dimensionality, enhance the signal to noise ratio, and improve interpretability of high-dimensional multi-trait genome-wide analyses.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Soheili-Nezhad, S., Beckmann, C. F., Sprooten, E.. 2022-07-14. Reproducibility of Principal and Independent Genomic Components of Brain Structure and Function. https://doi.org/10.1101/2022.07.13.499912

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗